Better aligning diagnostic and drug review processes should be one key focus of upcoming user fee negotiations, says Amy Miller.
Coalition Expects Higher Personalized Medicine Profile During User Fee Talks
Better coordination of device and drug review processes is crucial to the future of personalized medicine and are likely to be an important focus of upcoming user fee negotiations, says the Personalized Medicine Coalition's Amy Miller.